Anxiolytic-like effect of (4-benzylpiperazin-1-yl)(3-methoxyquinoxalin-2-yl)methanone (6g) in experimental mouse models of anxiety

dc.contributor.authorMahesh, R.
dc.date.accessioned2023-11-22T05:16:43Z
dc.date.available2023-11-22T05:16:43Z
dc.date.issued2013
dc.description.abstractThe present study was designed to investigate the anxiolytic activity of 6g, a novel serotonin type-3 receptor (5-HT 3) receptor antagonist in experimental mouse models of anxiety.en_US
dc.identifier.urihttps://ijp-online.com/article.asp?issn=0253-7613;year=2013;volume=45;issue=3;spage=248;epage=251;aulast=Bhatt;type=3
dc.identifier.urihttp://dspace.bits-pilani.ac.in:8080/xmlui/handle/123456789/13214
dc.language.isoenen_US
dc.publisherWolters Kluweren_US
dc.subjectPharmacyen_US
dc.subjectAnxietyen_US
dc.subjectElevated plus maze (EPM)en_US
dc.subjectHole-boarden_US
dc.subject5-HT3 receptor antagonisten_US
dc.subjectOpen field test (OFT)en_US
dc.titleAnxiolytic-like effect of (4-benzylpiperazin-1-yl)(3-methoxyquinoxalin-2-yl)methanone (6g) in experimental mouse models of anxietyen_US
dc.typeArticleen_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: